Insider Transactions in Q1 2016 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q1 2016)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 01
2016
|
Michael Gibertini |
SELL
Open market or private sale
|
Direct |
9,000
-15.99%
|
$351,000
$39.85 P/Share
|
Mar 01
2016
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+13.79%
|
$72,000
$8.45 P/Share
|
Feb 04
2016
|
Robert W Breckon Director |
SELL
Open market or private sale
|
Direct |
3,882
-12.45%
|
$151,398
$39.76 P/Share
|
Feb 04
2016
|
Robert W Breckon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,787
+19.9%
|
$22,296
$8.45 P/Share
|
Feb 01
2016
|
Gregory S Rush Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
17,752
-25.12%
|
$710,080
$40.85 P/Share
|
Feb 01
2016
|
Gregory S Rush Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,752
+31.91%
|
$284,032
$16.06 P/Share
|
Feb 01
2016
|
Michael Gibertini |
SELL
Open market or private sale
|
Direct |
9,000
-8.14%
|
$369,000
$41.01 P/Share
|
Feb 01
2016
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+13.79%
|
$72,000
$8.45 P/Share
|
Jan 19
2016
|
Gregory S Rush Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+37.35%
|
-
|
Jan 19
2016
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Grant, award, or other acquisition
|
Direct |
9,050
+35.64%
|
-
|
Jan 19
2016
|
D. Jamie Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+33.55%
|
-
|
Jan 19
2016
|
Alistair Macdonald Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+35.83%
|
-
|
Jan 19
2016
|
Michael Gibertini |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+18.87%
|
-
|
Jan 04
2016
|
Michael Gibertini |
SELL
Open market or private sale
|
Direct |
9,000
-10.45%
|
$414,000
$47.0 P/Share
|
Jan 04
2016
|
Michael Gibertini |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+16.58%
|
$72,000
$8.45 P/Share
|